SLASSLASInSimili wins SLAS Ignite AwardItalian InSimili Srl has been awarded the Ignite Award for the most innovative start-up company in the lab automation sector. The US$5,000 prize was presented by the Society for Laboratory Automation … more ➔
Alexandra Csuport Photography/SLASSLAS 2025SLAS: automation start ups set to enable P4 medicineOn the second day of SLAS 2025, the world’s largest laboratory automation conference in San Diego, the last two finalists of the Ignite Award pitched their business models. Meanwhile, the 10 finalists … more ➔
Commit Biologics A/S Seed FinancingCommit Biologics raises additional €5.5m seed financingDenmark’s complement system activator specialist Commit Biologics A/S has added a €5.5m extension to its €16.5 seed financing. New investor Korys joined Novo Holdings and Bioqube Ventures. more ➔
Markets & MarketsAutomation & Drug ScreeningSLAS opens with 409 exhibitors and 6,700 attendeesThe world’s most important conference for laboratory automation and drug screening tools, SLAS 2025 International, opens today in San Diego. One of the highlights will be the pitches for the best start-up, … more ➔
Wuxi BiologicsPartnershipSwiss AB2 Bio inks US$ 686m license option deal with Nippon ShinyakuNippon Shinyaku has secured an option to acquire exclusive US rights to commercialize AB2 Bio’s tadekinig alfa to treat primary monogenic IL-18 driven hyperinflammatory syndrome in patients with NLRC4 … more ➔
Project EadenMeat alternativesProject Eaden bags €15m to scale up productionBerlin-based food tech start-up Project Eaden is prepared to launch its first plant-based ham product by mid-year in 2,000 REWE supermarkets. A oversubscribes Series A financing laid the basis for this … more ➔
Adobe Stock - whitehoune FinancingCeres Brain Therapeutics announces €6m financingParis-based drug delivery specialist Ceres Brain Therapeutics SA has raised €6m led by ANJAC, a French family-owned industrial group and preferred partner of healthcare laboratories and beauty and … more ➔
Arctic TherapeuticsFinancingArctic Therapeutics ASA kicks off with €26.5m Series A roundIceland’s Arctic Therapeutics has secured €26.5m in a Series A financing aimed to push its oral drug candidates AT-O01 and AT-004 into clinical trails in patients with rare amyloid aggregation diseases … more ➔
EU ParliamentBiologisation of industryEuropaBio calling for EU Biotech ActEuropaBio calls for an ambitious cross-sectoral EU Biotech Act, that strengthens Europe as a global biotechnology leader for competitiveness and strategic autonomy. more ➔
adobe stock.com - HomuGallery EMAPRAC: Semaglutide linked to rare eye disease?The Safety Committee PRAC of the European Medicines Agency EMA is investigating a new potential adverse reaction to the appetite suppressant semaglutide. Epidemiological studies indicate that the rare … more ➔
SLAS
Alexandra Csuport Photography/SLAS
Commit Biologics A/S 
Markets & Markets
Wuxi Biologics
Project Eaden
Adobe Stock - whitehoune 
Arctic Therapeutics
EU Parliament
adobe stock.com - HomuGallery